Looks like you clickedhttps://www.novartis.com/uk-en/news/media-releases/mhra-grants-marketing-authorisation-novartis-radioligand-therapy-pluvictov-lutetium-177lu-vipivotide-tetraxetan-advanced-prostate-cancer-great-britain
If you do not want to visit that page, you can close this browser tab.
